A randomized Phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib maintenance (PC/G) with gefitinib monotherapy (G) in East Asian patients (pts) with locally advanced or metastatic nonsquamous non-small cell lung cancer (nSqNSCLC): Final survival results.
Resource
J. Clin. Oncol., 33(15),
Journal
J. Clin. Oncol.
Journal Volume
33
Journal Issue
15
Pages
-
Date Issued
2015
Date
2015
Author(s)
Yang, James Chih-Hsin
Srimuninnimit, Vichien
Ahn, Myung-Ju
Lin, Chia-Chi
Kim, Sang-We
Tsai, Chun-Ming
Mok, Tony
Orlando, Mauro
Puri, Tarun
Wang, Xin
Park, Keunchil
SDGs